Dr Sudha Rao, founder & director, Dhiti Omics
The trend of spinning-off start-ups by large organizations is heating up in India. In 2014, Genotypic Technology, a genomics service enterprise, spun-off its second start-up company, Dhiti Omics - a provider of precision molecular diagnostic services in multiple areas of specialization including Obstetrics or Gynecology, Pediatrics, Neurology, Cardiology, Nephrology and Oncology.
"Dhiti Omics was born out of a desire to extend the expertise in genomics gained over a decade into understanding and diagnosing disorders that are genetic in nature. We felt this was more an opportunity and a service that we could provide, not just to clinicians in India, but also in other countries who were looking for help with diagnosis and decisions related to targeted treatment for difficult and incurable diseases," explained Dr Sudha Rao, founder & director, Dhiti Omics, who has evolved from being a genetic researcher to an entrepreneur today.
The company has a cross-functional team with expertise in genomics, bioinformatics, healthcare and technology.
One of the important aspects of clinical genomics is to efficiently analyze the data and pinpoint the disease-causing variant from gigabytes (GB) of data.